No evidence for enhanced disease with polyclonal SARS-CoV-2 antibody in the ferret model.
D. S. Reed, A. McElroy, D. Barbeau, C. McMillen, N. Tilston-Lunel, S. Nambulli, E. Cottle, T. Gilliland, H. Rannulu, J. Lundy, E. Olsen, K. O'Malley, M. Xia, A. Hartman, T. Luke, , P. Duprex
This study tests if polyclonal SARS-CoV-2 antibodies enhance disease in ferrets, finding no significant differences in symptoms or viral shedding between antibody-treated and control groups.
bioRxiv · Aug 19, 2023 · PreprintMicrobiology